Distinguishing RBL-like objects and XBL-like objects with the peak emission frequency of the overall energy spectrum

We investigate quantitatively how the peak emission frequency of the overall energy spectrum is at work in distinguishing RBL-like and XBL-like objects. We employ the sample of Giommi et al. (1995) to study the distribution of BL Lacertae objects with various locations of the cutoff of the overall energy spectrum. We find that the sources with the cutoff located at lower frequency are indeed sited in the RBL region of the $\alpha_{ro}-\alpha_{ox}$ plane, while those with the cutoff located at higher frequency are distributed in the XBL region. For a more quantitative study, we employ the BL Lacertae samples presented by Sambruna et al. (1996), where, the peak emission frequency, $\nu _p$, of each source is estimated by fitting the data with a parabolic function. In the plot of $\alpha_{rx}-\log \nu_p$ we find that, in the four different regions divided by the $\alpha_{rx}=0.75$ line and the $\log \nu_p=14.7$ line, all the RBL-like objects are inside the upper left region, while most XBL-like objects are within the lower right region. A few sources are located in the lower left region. No sources are in the upper right region. This result is rather quantitative. It provides an evidence supporting what Giommi et al. (1995) suggested: RBL-like and XBL-like objects can be distinguished by the difference of the peak emission frequency of the overall energy spectrum.Comment: 7 pages, 2 figure

The hardness-duration correlation in the two classes of gamma-ray bursts

The well-known hardness-duration correlation of gamma-ray bursts (GRBs) is investigated with the data of the 4B catalog. We find that, while the hardness ratio and the duration are obviously correlated for the entire set of the 4B catalog, they are not at all correlated for the two subsets divided at the duration of 2 seconds. However, for other subsets with comparable sizes, the two quantities are significantly correlated. The following conclusions are then reached: (1) the existence of two classes of GRBs is confirmed; (2) the hardness ratio and the duration are not at all correlated for any of the two classes; (3) different classes of GRBs have different distributions of the hardness ratio and the duration and it is this difference that causes the correlation between the two quantities for the entire set of the bursts.Comment: 5 pages, 1 figure, accepted for publication in PAS

Poly[[bis­(μ-4,4′-bipyridine-κ2 N:N′)copper(I)] perchlorate 0.24-hydrate]

The title copper(I) polymeric compound, {[Cu(C10H8N2)2]ClO4·0.24H2O}n, obtained by the reaction of Cu(ClO4)2 and 4,4′-bipyridine (4,4′-bpy) under hydro­thermal conditions, features a fourfold-inter­penetrated diamondoid coordination framework. The asymmetric unit consists of two CuI atoms, three 4,4′-bpy ligands in general positions and two halves of two centrosymmetric 4,4′-bpy ligands, two ClO4 − anions and water mol­ecule with a site-occupancy factor of 0.480 (17). The CuI atoms are in a distorted tetra­hedral coordination environment and are bridged by 4,4′-bpy ligands, forming a diamondoid cationic polymeric framework that encloses two symmetry-independent channels along [100], which accommodate perchlorate anions and water mol­ecules

XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis

Genetic polymorphism of X-ray repair crosscomplementing group 3 (XRCC3) Thr241Met has been implicated to alter the risk of ovarian cancer, but the results are controversial. In order to get a more precise result, a meta-analysis was performed. All eligible studies were identified through an extensive search in PubMed, Excerpta Medica Database (Embase), Chinese National Knowledge Infrastructure database, and Chinese Biomedical Literature Database before August 2013. The association between the XRCC3 Thr241Met polymorphism and ovarian cancer risk was conducted by odds ratios (ORs) and 95 % confidence intervals (95 % CIs). Finally, a total of four publications including seven studies with 3,635 cases and 5,473 controls were included in our meta-analysis. Overall, there was no association between XRCC3 Thr241Met polymorphism and risk of ovarian cancer under all five genetic models in overall population (T vs. C: OR = 0.99, 95 % CI = 0.960–1.03, P = 0.752; TT vs. CC: OR = 1.00, 95 % CI = 0.91–1.10, P = 0.943; TC vs. TT: OR = 0.97, 95 % CI = 0.92–1.04, P = 0.396, Fig. 1; TT vs. TC/CC: OR = 1.00, 95 % CI = 0.91–1.12, P = 0.874; TT/TC vs. CC: OR = 0.98, 95 % CI = 0.94–1.03, P = 0.486). In the subgroup analysis according to ethnicity, the results suggested that XRCC3 Thr241Met polymorphism was not associated with the risk of ovarian cancer in Caucasians population. No significant association was found between the XRCC3 Thr241 Met polymorphism and the risk of ovarian cancer. Given the limited sample size and ethnicities included in the meta-analysis, further large scaled and well-designed studies are needed to confirm our results

An experimental investigation on the mechanical properties of the interface between large-sized graphene and a flexible substrate

In this paper, the interfacial mechanical properties of large-sized monolayer graphene attached to a flexible polyethylene terephthalate (PET) substrate are investigated. Using a micro-tensile test and Raman spectroscopy, in situ measurements are taken to obtain the full-field deformation of graphene subjected to a uniaxial tensile loading and unloading cycle. The results of the full-field deformation are subsequently used to identify the status of the interface between the graphene and the substrate as one of perfect adhesion, one showing slide or partial debonding, and one that is fully debonded. The interfacial stress/strain transfer and the evolution of the interface from one status to another during the loading and unloading processes are discussed and the mechanical parameters, such as interfacial strength and interfacial shear strength, are obtained quantitatively demonstrating a relatively weak interface between large-sized graphene and PET

Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis

In the light of the relationship between the MDR1 G2677T polymorphism and the risk of leukemia remains inclusive or controversial. For better understanding of the effect of MDR1 G2677T polymorphism on leukemia risk, we performed a meta-analysis. Eligible studies were identified through a search of electronic databases such as PubMed, Excerpta Medica Database (Embase), Cochrane Library, and Chinese Biomedical Literature Database (CBM). The association between the MDR1 G2677T polymorphism and leukemia risk was conducted by odds ratios (ORs) and 95 % confidence intervals (95 % CI). A total of seven publications including eight studies with 1,229 cases and 1,097 controls were included in the meta-analysis. There was no association between MDR1 G2677T polymorphism and leukemia risk in all of five models in overall populations (T vs. G: OR = 1.00, 95 % CI = 0.88–1.12, P = 0.914; TT vs. GG: OR = 0.97, 95 % CI = 0.75–1.26, P = 0.812; TG vs. GG: OR = 1.00, 95 % CI = 0.92–1.08, P = 0.939; TT vs. TG/GG: OR = 0.98, 95 % CI = 0.67–1.43, P = 0.906; TT/TG vs. GG: OR = 1.00, 95 % CI = 0.95–1.06, P = 0.994). However, the significant association was found in others (Table 2) under the homozygote model (TT vs. GG: OR = 0.68, 95 % CI = 0.48–0.94, P = 0.020) and recessive model (TT vs. TG/GG: OR = 0.63, 95 % CI = 0.43–0.92, P = 0.016). In the subgroup analysis, according to the type of leukemia, significant association was found between MDR1 G2677T polymorphism and myeloid leukemia but not lymphoblastic leukemia (TT vs. GG: OR = 0.66, 95 % CI = 0.46–0.95, P = 0.026; TT vs. TG/GG: OR = 0.56, 95 % CI = 0.38–0.84, P = 0.005). The results suggested that there was no association between MDR1 G2677T polymorphism and leukemia risk in overall populations, but significant association was found in others populations (Asians and Africans), and myeloid leukemia indicated that G2677T polymorphism might be a protective factor in the susceptibility of myeloid leukemia and in Asians and Africans

Association between Tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis

BACKGROUND: Tumor necrosis factor-alpha (TNF-α) is an important inflammatory cytokine that may play a role in controlling the progression of prostate cancer. Two common polymorphisms in the TNF-α gene, −308G/A and −238C/T, have been suggested to alter the risk for prostate cancer, but the results have been inconclusive so far. In order to obtain a better understanding of the effects of these two polymorphisms on prostate cancer risk, all available studies were considered in a meta-analysis. METHODS: We conducted a comprehensive literature search in the Cochrane Library, PubMed, EMBASE, Chinese Biomedical Literature database (CBM), and the China National Knowledge Infrastructure (CNKI). The associations were evaluated by calculating the pooled odds ratio (OR) with 95% confidence interval (95% CI). RESULTS: In this meta-analysis, we included 14 studies with 5,757 patients and 6,137 control subjects for the TNF-α-308G/A polymorphism and 1,967 patients and 2,004 control subjects for the TNF-α-238C/T polymorphism. A significantly increased prostate cancer risk was found to be associated with the TNF-α-308C/T polymorphism in studies with healthy volunteers (AA + AG vs. GG: OR = 1.531, 95% CI = 1.093–2.145; P = 0.013; AG vs. GG: OR = 1.477, 95% CI = 1.047–2.085; P = 0.026). No significant association was found between the TNF-α-238G/A polymorphism and prostate cancer risk in the overall or subgroup analyses. There was no risk of publication bias in this meta-analysis. CONCLUSIONS: Our results suggest that while the TNF-α-238G/A polymorphism may not be associated with prostate cancer the TNF-α-308C/T polymorphism may significantly contribute to prostate cancer susceptibility in healthy volunteers. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/162928812011630

Phylogenetic distribution and predominant genotype of the avian infectious bronchitis virus in China during 2008-2009

<p>Abstract</p> <p>Background</p> <p>The nephropathogenic avian infectious bronchitis (IB) caused unprecedented economic losses to the commercial chicken industry of China in 2008-2009. To investigate the prevalence of nephropathogenic IB in China, eighty IBV isolates from different provinces during 2008-2009 were identified by dwarf embryo test and RT-PCR.</p> <p>Results</p> <p>The strains were mostly isolated in winter and spring with a wide age range of IB outbreaks, from 4 to 69 days. By the virus recovery trials, 70/80 of the strains resulted in the deaths or distresses of birds from nephritis. To learn more about the molecular evolutionary characteristics of the circulating field strains, the coding region of major spike 1 (S1) protein gene of these strains was RT-PCR amplified and sequenced. Compared to the published representative strains, nucleotides and amino acids sequence analysis indicated that the S1 genes of these strains and the reference strains displayed homologies ranging from 75.1% to 99.8% and from 73.1% to 99.8% respectively. S1 protein of the major pandemic strains contained 540 or 542 amino acids with the cleavage site of HRRRR or RRFRR. Phylogenetic analysis revealed that recent field isolates of IBV in China were mostly belonged to A2-branch (QXIBV-branch) and HN08-branch, only one isolate was belonged to Gray-branch and M41-branch respectively. Most of the 80 strains showed evolutionarily distant from vaccine strains.</p> <p>Conclusions</p> <p>The results of this study suggested that nephropathogenic IBVs were mainly A2-like strains in China during 2008-2009.</p